Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma

Abstract The aim of the study was to assess the predictive value of interim FDG-PET/CT (iPET) in patients with Hodgkin’s lymphoma (HL) treated with Adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy. A total of 245 consecutive patients with de novo HL between 12/2013 and 12/2017...

Full description

Bibliographic Details
Main Authors: Akram Al-Ibraheem, Farah Anwer, Malik E. Juweid, Qaid Ahmed Shagera, Aysar N. Khalaf, Shahed Obeidat, Areen Mansour, Mohammad Ma’koseh, Khalid Halahleh, Imad Jaradat, Nidal Almasri, Asem Mansour
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-22032-3

Internet

https://doi.org/10.1038/s41598-022-22032-3

Similar Items